You should know that you are questioning the wrong audience. It's not the FDA's responsibility to make public shareholders aware of what's going on with their investment, it's Prana Biotech's. Apparently they're not ready to talk.
SRPT Duchenne Drug trial hits 5 year mark, page-54
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $6.168K | 1.542M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 52445756 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127138639 | 21 |
View Market Depth
| Last trade - 09.59am 15/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |